The impact of foreign influence across multiple sectors of the United States economy continues to be a national concern. Specific to academia and health care, the National Institutes of Health (NIH) has raised concerns regarding the security of intellectual property and the integrity of the peer review process for biomedical research, which was outlined by NIH Director Dr. Francis Collins in an August 2018 statement. Three areas of concern...
Researchers at The University of Texas MD Anderson Cancer Center have discovered that triple negative breast cancer (TNBC) cells can develop...
The University of Texas MD Anderson Cancer Center proudly presents End Cancer Night at BBVA Compass Stadium Saturday, April 27 at 7 p.m. as...
A study at The University of Texas MD Anderson Cancer Center revealed the investigational drug umbralisib as an effective treatment for patients with relapsed marginal zone lymphoma (MZL). Findings from the Phase II trial were presented by study co-lead Nathan Fowler, M.D., associate professor in the Department of Lymphoma & Myeloma, at the AACR Annual Meeting 2019 in Atlanta.
MZL is a low-grade non-Hodgkin lymphoma that accounts...
Cancer cells demand enormous amounts of molecular “food” to survive and grow, and a study published March 27 online in Nature by researchers...
White blood cells known as B cells have been shown to be effective for predicting which cancer patients will respond to immune checkpoint...
Researchers at The University of Texas MD Anderson Cancer Center revealed the common oncogene KRAS as a possible explanation for why many...
The University of Texas MD Anderson Cancer Center presents its Making Cancer History® Seminar, 11:30 a.m.-1:30 p.m. March 25 at the Hotel...
Lung cancer is the leading cancer killer, yet coverage of screenings for individuals at high risk for lung cancer varies across state Medicaid...
A cellular identity switch protects a cancer-promoting genetic pathway from targeted therapy, researchers at The University of Texas MD Anderson...